STOCK TITAN

Regeneron director Sing proposes $960K share sale

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

Regeneron Pharmaceuticals, Inc. director George L. Sing filed notice of a proposed sale of 1,000 common shares, with an approximate sale date of November 16, 2026 and an aggregate market value of $960,264.40. The notice lists the shares as acquired from the issuer through a private acquisition for cash on April 9, 1991. It also reports that Sing sold 21,129 common shares on November 2, 2026, for gross proceeds of $20,376,359.76.

Proposed sale 1,000 common shares Approximate sale date: November 16, 2026
Aggregate market value $960,264.40 For the proposed sale of 1,000 common shares
Shares outstanding 101,630,713 shares Reported in the securities information section
Prior sale 21,129 common shares Sold November 2, 2026
Gross proceeds $20,376,359.76 From the November 2, 2026 sale
Shares acquired 1,000 common shares Acquired April 9, 1991, through a private acquisition from the issuer for cash
Aggregate Market Value financial
"Aggregate Market Value of 960264.40"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.
Gross Proceeds financial
"Gross Proceeds 20376359.76"
The total amount of cash a company receives from a financing event or sale before any fees, expenses, taxes or deductions are taken out. Investors watch gross proceeds because it shows the raw scale of new capital being raised—think of it as the paycheck amount before withholdings—which helps assess how much funding is available for operations, growth, debt payoff or how much shareholder dilution might occur once costs are removed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many REGN shares does George L. Sing plan to sell?

George L. Sing, a director of Regeneron Pharmaceuticals, Inc., reported a proposed sale of 1,000 common shares, with an approximate sale date of November 16, 2026 and aggregate market value of $960,264.40.

How many REGN shares did George L. Sing sell recently?

The notice reports that George L. Sing sold 21,129 common shares on November 2, 2026, for gross proceeds of $20,376,359.76.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading